AstraZeneca sells older asthma, rhinitis drugs for $350 mln Medical Dialogues Bureau9 Nov 2018 9:05 AM ISTLONDON: AstraZeneca is selling three older drugs for asthma and rhinitis for at least $350 million as the company continues a strategy of divesting...
NBCC inks pact with Health Ministry to buy out HSCC Medical Dialogues Bureau8 Nov 2018 10:00 AM ISTIn September, NBCC had said it will buy out the government's stake in consultancy firm HSCC for Rs 285 crore.New Delhi: State-owned NBCC has recently...
Suven Life Sciences gets Product Patents in Israel and Japan Medical Dialogues Bureau8 Nov 2018 9:25 AM ISTHYDERABAD: Suven Life Sciences Ltd has recently announced the grant of one product patent from Israel and one product patent from Japan corresponding...
Foamix's treatment for common skin condition meets late-stage trial goals Medical Dialogues Bureau8 Nov 2018 9:00 AM ISTFoamix hopes to be the first to bring a foam formation of minocycline, which is typically available in oral dosage forms, to the market.New Delhi:...
Cipla Q2 consolidated net profit declines by 15.64 percent Medical Dialogues Bureau7 Nov 2018 9:45 AM ISTMumbai: Pharma major, Cipla Ltd has posted a decline of 15. 64 per cent in its consolidated net profit for the quarter ended September 30, 2018, at Rs...
FDA approves Pfizer's Lorbrena treatment for certain lung cancer patients Medical Dialogues Bureau7 Nov 2018 9:40 AM ISTLorbrena, known chemically as lorlatinib, received an accelerated approval, Pfizer said. Its continued approval may depend on verification of clinical...
Natco Pharma Q2 Profit up 35 percent to Rs 583 Crore Medical Dialogues Bureau7 Nov 2018 9:15 AM ISTHyderabad: Natco Pharma Limited has recorded consolidated total revenue of INR 583.50 Crore for the second quarter ended on 30th September 2018, as...
Sanofi and Regeneron's Dupixent gets more positive feedback from U.S.FDA Medical Dialogues Bureau7 Nov 2018 9:05 AM ISTPARIS: The U.S. Food & Drug Administration (FDA) regulator has given more positive feedback on the Dupixent eczema treatment being developed by...
Lupin gets FDA approval for Doxercalciferol Injection Medical Dialogues Bureau6 Nov 2018 1:03 PM ISTNew Delhi: Pharma major Lupin announced that it has received approval for its Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) Multi-dose Vials from...
Faulty Implant: J&J launches IPAP Reimbursement Programme Medical Dialogues Bureau6 Nov 2018 10:15 AM ISTJohnson & Johnson Private Limited has launched the (ASR) Articular Surface Replacement) India Patient Assistance Program (IPAP) - a unique program...
Bliss GVS Pharma Q2 profit up 22 Percent to Rs 41.45 crore Medical Dialogues Bureau6 Nov 2018 9:21 AM ISTNEW Delhi: Bliss GVS Pharma on has reported a 22 per cent increase in consolidated profit to Rs 41.45 crore in the second quarter ended September 30,...
Roche's Schwan says new drugs will replace lost sales - NZZ am Sonntag Medical Dialogues Bureau6 Nov 2018 9:05 AM ISTNew Delhi: Roche Cheif Executive Severin Schwan has announced that new drugs the pharma company is developing will replace the roughly 10 billion...
